HRTX Q2 2020 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M-38.2% YoY

Gross Profit

$14M60.3% margin

Operating Income

-$56M-245.9% margin

Net Income

-$55M-243.5% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

-10.8%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$58M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$433M

Total Liabilities

$109M

Stockholders' Equity

$324M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$37M	-38.2%
Gross Profit	$14M	$23M	-40.8%
Operating Income	-$56M	-$52M	-7.7%
Net Income	-$55M	-$50M	-9.9%

Revenue Segments

C I N V A N T I

$23M100%

S U S T O L

$100,0000%